Peter Bollmann
Plus aucun poste en cours
Provenance du réseau au premier degré de Peter Bollmann
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
22
| Public Company | Pharmaceuticals: Major | 22 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Peter Bollmann via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| SWISS LIFE HOLDING AG | Life/Health Insurance | Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Graduate Degree | |
| EVOTEC SE | Pharmaceuticals: Major | Chief Executive Officer | |
| SCHINDLER HOLDING AG | Industrial Machinery | Director/Board Member | |
| HUBER+SUHNER AG | Telecommunications Equipment | Director/Board Member | |
| SCHWEIZERISCHE NATIONALBANK | Major Banks | Director/Board Member | |
Cardion GmbH
 Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Medical Specialties | Corporate Officer/Principal | |
| University of Tilburg | College/University | Corporate Officer/Principal | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| University of Vienna | College/University | Doctorate Degree | |
| University of St. Gallen | College/University | Corporate Officer/Principal | |
| ADDEX THERAPEUTICS LTD | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Federation of Austrian Industry
 Federation of Austrian Industry Miscellaneous Commercial ServicesCommercial Services The Federation of Austrian Industry is an organization that focuses on the observation and analysis of international developments, trade and investment agreements, and the conditions of fair international competition. The non-profit company is based in Vienna, Austria. Austria is a small but highly export-oriented economy, and the organization believes that for the future growth and prosperity of the country, its companies must have the best possible framework to take advantage of their international opportunities. The organization emphasizes the importance of sustainable international relationships and free and fair trade to ensure Austria's export capability and access to markets. The CEO of the Austrian company is Martin Ohneberg. | Miscellaneous Commercial Services | Director/Board Member | |
| University of Zurich | College/University | Undergraduate Degree | |
| University of Milan | College/University | Doctorate Degree | |
| University of Lausanne | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of Bern | College/University | Undergraduate Degree | |
| Medical College of Virginia | College/University | Doctorate Degree | |
| Heinrich-Heine-Universität Düsseldorf | College/University | Doctorate Degree | |
Pantec Biosolutions AG
 Pantec Biosolutions AG Drugstore ChainsRetail Trade Pantec Biosolutions AG provides laser microporation based transdermal drug delivery services. Its technology can be used for transdermal delivery, intradermal delivary, epidermal delivery, infertility patches, and aesthetic dermatology. The company was founded by Christof Böhler, Herbert Zech, Reinhard Braun, Werner Braun, and Thomas Bragagna in 2006 and is headquartered in Ruggell, Liechtenstein. | Drugstore Chains | Director/Board Member | |
| DIMERIX LIMITED | Pharmaceuticals: Major | Director/Board Member | |
| Basel Institute for Immunology | College/University | Corporate Officer/Principal | |
| NOVIMMUNE SA | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| ARGENX SE | Pharmaceuticals: Other | Director/Board Member | |
| Serono Pharmaceutical Research Institute | Corporate Officer/Principal | ||
| Glaxo-Welcomes' Research Institute | Corporate Officer/Principal | ||
HUBER+SUHNER (UK) Ltd.
 HUBER+SUHNER (UK) Ltd. Electronic Production EquipmentElectronic Technology HUBER+SUHNER (UK) Ltd. manufactures, imports, and sells electrical and optical connectivity components and accessories. It offers radio frequency and fiber optic products including antennas, assemblies, cables, connectors and adapters, lightning and EMP protectors, and resistive components. The company was founded on March 30, 1967 and is headquartered in Bicester, the United Kingdom. | Electronic Production Equipment | Director/Board Member | |
| World Demographic & Ageing Forum | Corporate Officer/Principal | ||
| Gebert Rüf Stiftung | Corporate Officer/Principal | ||
| Network for Studies on Pensions Aging Retirement | Corporate Officer/Principal | ||
| Swiss Institute for Empirical Economic Research | Director/Board Member | ||
| Institute of Public Finance & Fiscal Law | Corporate Officer/Principal | ||
| Center for Disability & Integration | Corporate Officer/Principal | ||
| CESifo Research Network | Corporate Officer/Principal | ||
| Swiss Federal Commission for Economic Issues | Corporate Officer/Principal | ||
| Max Schmidheiny-Stiftung | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Dimerix Bioscience Pty Ltd.
 Dimerix Bioscience Pty Ltd. Medical DistributorsDistribution Services Dimerix Bioscience Pty Ltd. engages in the development and commercialization of drug therapies and drug discovery tools. It deals with clinical research organizations to progress its programs through clinical studies. It focuses on the clinical development of its therapeutic product DMX200 which is targeted to treat patients with chronic kidney disease. The company was founded by James Howard Williams on December 16, 2004 and is headquartered in Melbourne, Australia. | Medical Distributors | Chief Executive Officer | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| Swiss Institute For Intl Economics & Applied Economic Research | Chairman | ||
| Swiss Society of Economics & Statistics | President | ||
| Richard Büchner Foundation | Director/Board Member | ||
Topas Therapeutics GmbH
 Topas Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Topas Therapeutics GmbH engages in pharmaceutical preparations. The company is headquartered in Hamburg, Germany. | Pharmaceuticals: Major | Chairman | |
Evotec (UK) Ltd.
 Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. | Miscellaneous Commercial Services | Director/Board Member |
Statistiques
Internationale
| Suisse | 24 |
| Etats-Unis | 7 |
| Allemagne | 7 |
| Autriche | 4 |
| Pays-Bas | 4 |
Sectorielle
| Health Technology | 15 |
| Consumer Services | 13 |
| Finance | 3 |
| Electronic Technology | 3 |
| Commercial Services | 3 |
Opérationnelle
| Director/Board Member | 96 |
| Corporate Officer/Principal | 53 |
| Independent Dir/Board Member | 25 |
| Chairman | 22 |
| Chief Tech/Sci/R&D Officer | 19 |
Relations les plus connectées
| Insiders | |
|---|---|
| Friedrich von Bohlen und Halbach | 36 |
| Alan Colowick | 27 |
| Monika Bütler | 25 |
| Douglas Williams | 25 |
| Martin Velasco | 15 |
| Werner Lanthaler | 12 |
| Thomas Graney | 11 |
| Carl June | 9 |
| Monica Shaw | 8 |
| Sonia Maria Poli | 7 |
| Marie Kosco-Vilbois | 7 |
| Jörg Hornstein | 7 |
| Roy Ervin Twyman | 6 |
| Piergiorgio Donati | 5 |
| Julien Rongère | 5 |
- Bourse
- Insiders
- Peter Bollmann
- Connexions Sociétés
